Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Labrid cleaner fishes show kinematic convergence as juveniles despite variation in morphology.

Baliga VB, Bernstein ZJ, Sundaram S, Mehta RS.

J Exp Biol. 2017 Aug 1;220(Pt 15):2787-2797. doi: 10.1242/jeb.153783. Epub 2017 May 17.

2.

Postoperative chemotherapy in gastric cancer, consisting of etoposide, doxorubicin and cisplatin, followed by radiotherapy with concomitant cisplatin: A feasibility study.

Shulman K, Haim N, Wollner M, Bernstein Z, Abdah-Bortnyak R, Bar-Sela G.

Oncol Lett. 2012 May;3(5):1154-1158. Epub 2012 Feb 24.

3.

Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.

Smonskey MT, Block AW, Deeb G, Chanan-Khan AA, Bernstein ZP, Miller KC, Wallace PK, Starostik P.

Am J Clin Pathol. 2012 Apr;137(4):641-6. doi: 10.1309/AJCPP31FSSRQTTAQ.

PMID:
22431542
4.

No sweat, a rare case of hidradenocarcinoma.

Singh R, Brewer J, Bernstein ZP, Higgs D.

Am Surg. 2012 Feb;78(2):92-3. No abstract available.

PMID:
22369809
5.
6.

Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease.

Mahajan SD, Agosto-Mojica A, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Martinez J, Adams J, Singh N, Bernstein Z, Hsiao CB, Schwartz SA.

Biochem Biophys Res Commun. 2010 May 28;396(2):348-52. doi: 10.1016/j.bbrc.2010.04.095. Epub 2010 Apr 21.

7.

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.

Chanan-Khan A, Miller KC, Musial L, Padmanabhan S, Yu J, Ailawadhi S, Sher T, Mohr A, Bernstein ZP, Barcos M, Patel M, Iancu D, Lee K, Czuczman MS.

Leuk Lymphoma. 2009 Jul;50(7):1096-101. doi: 10.1080/10428190902912460.

PMID:
19479618
8.

EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Matzinger O, Gerber E, Bernstein Z, Maingon P, Haustermans K, Bosset JF, Gulyban A, Poortmans P, Collette L, Kuten A.

Radiother Oncol. 2009 Aug;92(2):164-75. doi: 10.1016/j.radonc.2009.03.018. Epub 2009 Apr 15. Review.

PMID:
19375186
9.

Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network.

Stein ME, Bernstein Z, Abacioglu U, Sengoz M, Miller RC, Meirovitz A, Zouhair A, Freixa SV, Poortmans PH, Ash R, Kuten A.

Am J Med Sci. 2008 Dec;336(6):478-88. doi: 10.1097/MAJ.0b013e3181731e58.

PMID:
19092321
10.

Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.

Budiharto T, Musat E, Poortmans P, Hurkmans C, Monti A, Bar-Deroma R, Bernstein Z, Tienhoven Gv, Collette L, Duclos F, Davis B, Aird E; EORTC Radiation Oncology Group.

Radiother Oncol. 2008 Sep;88(3):403-10. doi: 10.1016/j.radonc.2008.05.013. Epub 2008 Jun 4.

PMID:
18538427
11.

Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light.

Bernstein ZP, Dougherty T, Gollnick S, Schwartz SA, Mahajan SD, Kepner J, Sumlin A, Stewart C, Wallace P, Adal A, Walder H, Poiesz B.

Curr HIV Res. 2008 Mar;6(2):152-63.

PMID:
18336263
12.

[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].

Abdah-Bortnyak R, Bernstein Z, Ramon N, Zalman D, Shnaider J, Kuten A.

Harefuah. 2007 Feb;146(2):126-8, 164-5. Review. Hebrew.

PMID:
17352282
13.

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

Chanan-Khan A, Miller KC, Musial L, Lawrence D, Padmanabhan S, Takeshita K, Porter CW, Goodrich DW, Bernstein ZP, Wallace P, Spaner D, Mohr A, Byrne C, Hernandez-Ilizaliturri F, Chrystal C, Starostik P, Czuczman MS.

J Clin Oncol. 2006 Dec 1;24(34):5343-9. Epub 2006 Nov 6.

PMID:
17088571
14.

Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.

Baxter MS, Schroeder WS, Cheng Y, Bernstein ZP.

Ann Pharmacother. 2006 Nov;40(11):2053-8. Epub 2006 Oct 24.

PMID:
17062831
15.

A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

Shah MH, Freud AG, Benson DM Jr, Ferkitich AK, Dezube BJ, Bernstein ZP, Caligiuri MA.

Clin Cancer Res. 2006 Jul 1;12(13):3993-6.

16.

Nasopharyngeal carcinoma in the pediatric age group: the northern Israel (Rambam) medical center experience, 1989-2004.

Haimi M, Arush MW, Bar-Sela G, Gez E, Bernstein Z, Postovsky S, Barak AB, Kuten A.

J Pediatr Hematol Oncol. 2005 Oct;27(10):510-6.

PMID:
16217252
17.

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).

Chanan-Khan A, Miller KC, Takeshita K, Koryzna A, Donohue K, Bernstein ZP, Mohr A, Klippenstein D, Wallace P, Zeldis JB, Berger C, Czuczman MS.

Blood. 2005 Nov 15;106(10):3348-52. Epub 2005 Jul 28.

PMID:
16051743
18.

Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients.

Nair MP, Mahajan SD, Schwartz SA, Reynolds J, Whitney R, Bernstein Z, Chawda RP, Sykes D, Hewitt R, Hsiao CB.

J Immunol. 2005 Jun 1;174(11):6617-26.

19.

Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.

Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH.

J Clin Oncol. 2005 Feb 1;23(4):694-704.

PMID:
15681517
20.

Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.

Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy PL Jr.

Transplantation. 2004 Nov 27;78(10):1515-22.

PMID:
15599317
21.

Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAART.

Srinivasan S, Takeshita K, Holkova B, Czuczman MS, Miller K, Bernstein ZP, Driscoll D, Chanan-Khan A.

HIV Clin Trials. 2004 May-Jun;5(3):140-5.

PMID:
15248138
22.

Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution?

Nikolsky E, Gruberg L, Rosenblatt E, Grenadier E, Boulos M, Bernstein Z, Huber A, Gitman R, Bar-Deroma R, Markiewicz W, Beyar R.

Int J Cardiovasc Intervent. 2004;6(1):33-8.

PMID:
15204171
23.

Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.

Hahn T, Rondeau C, Shaukat A, Jupudy V, Miller A, Alam AR, Baer MR, Bambach B, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack J, Wetzler M, Mookerjee BK, Silva J, McCarthy PL Jr.

Bone Marrow Transplant. 2003 Aug;32(4):405-10.

PMID:
12900777
24.

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.

Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR, Czuczman MS, Bernstein ZP, Chanan-Khan AA, Becker JL, McCarthy PL.

Bone Marrow Transplant. 2003 Jul;32(2):139-43.

PMID:
12838277
25.

A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS.

Cancer. 2002 Dec 15;95(12):2555-61.

26.

Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study.

Stein ME, Bernstein Z, Tsalic M, Drumea K, Steiner M, Sklar Z, Haim N.

Am J Clin Oncol. 2002 Oct;25(5):460-3.

PMID:
12393984
27.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS.

Bernstein ZP, Brooks SP, Chanan-Khan A, Gollnick SO, Gilbert MJ, Miller KC, Tomasi TB.

HIV Clin Trials. 2002 May-Jun;3(3):219-24.

PMID:
12032880
28.

A prospective single-center registry for the use of intracoronary gamma radiation in patients with diffuse in-stent restenosis.

Nikolsky E, Rosenblatt E, Grenadier E, Boulos M, Roguin A, Patil C, Bernstein Z, Huber A, Ben-Zvi M, Bar-Deroma R, Markiewicz W, Beyar R.

Catheter Cardiovasc Interv. 2002 May;56(1):46-52.

PMID:
11979533
29.

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

Czuczman MS, Fallon A, Mohr A, Stewart C, Bernstein ZP, McCarthy P, Skipper M, Brown K, Miller K, Wentling D, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-López AJ, Bernstein SH.

Semin Oncol. 2002 Feb;29(1 Suppl 2):36-40. Review.

PMID:
11842387
30.

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

Czuczman MS, Fallon A, Mohr A, Stewart C, Bernstein ZP, McCarthy P, Skipper M, Brown K, Miller K, Wentling D, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-López AJ, Bernstein SH.

Semin Oncol. 2002 Feb;29(1S2):36-40. doi: 10.1053/sonc.2002.30152.

PMID:
28140090
31.

Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.

Khushalani NI, Bakri FG, Wentling D, Brown K, Mohr A, Anderson B, Keesler C, Ball D, Bernstein ZP, Bernstein SH, Czuczman MS, Segal BH, McCarthy PL Jr.

Bone Marrow Transplant. 2001 May;27(10):1071-3. Review.

32.

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.

Simon M, Hahn T, Ford LA, Anderson B, Swinnich D, Baer MR, Bambach B, Bernstein SH, Bernstein ZP, Czuczman MS, Slack JL, Wetzler M, Herzig G, Schriber J, McCarthy PL Jr.

Bone Marrow Transplant. 2001 Mar;27(6):627-33.

33.

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.

Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, Belling L, Holmberg P, MacLaughlin W, Howard F.

Haemophilia. 2000 Nov;6(6):643-8.

PMID:
11122390
34.

Cytokine replacement in patients with HIV-1 non-Hodgkin's lymphoma: the rationale for low-dose interleukin-2 therapy.

Shah MH, Baiocchi RA, Fehniger TA, Khatri VP, Gould M, Poiesz B, Bernstein ZP, Caligiuri MA.

Cancer J Sci Am. 2000 Feb;6 Suppl 1:S45-51. Review.

PMID:
10685658
35.

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma.

Bernstein ZP, Wilson BD, Oseroff AR, Jones CM, Dozier SE, Brooks JS, Cheney R, Foulke L, Mang TS, Bellnier DA, Dougherty TJ.

AIDS. 1999 Sep 10;13(13):1697-704.

PMID:
10509571
36.

Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.

Stein ME, Bernstein Z, Drumea K, Zalik M, Shklar Z, Steiner M, Haim N.

Am J Clin Oncol. 1999 Feb;22(1):62-4.

PMID:
10025383
37.

Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma.

Scadden DT, Schenkein DP, Bernstein Z, Luskey B, Doweiko J, Tulpule A, Levine AM.

Cancer. 1998 Dec 15;83(12):2580-7.

PMID:
9874466
38.

Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.

Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, O'Brien WA, Caligiuri MA.

J Immunol. 1998 Dec 1;161(11):6433-8.

39.

Proglumide as a morphine adjunct in cancer pain management.

Bernstein ZP, Yucht S, Battista E, Lema M, Spaulding MB.

J Pain Symptom Manage. 1998 May;15(5):314-20.

40.

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Khatri VP, Fehniger TA, Baiocchi RA, Yu F, Shah MH, Schiller DS, Gould M, Gazzinelli RT, Bernstein ZP, Caligiuri MA.

J Clin Invest. 1998 Mar 15;101(6):1373-8.

41.

Role of transforming growth factor-beta1 in the suppressed allostimulatory function of AIDS patients.

Brooks SP, Bernstein ZP, Schneider SL, Gollnick SO, Tomasi TB.

AIDS. 1998 Mar 26;12(5):481-7.

PMID:
9543446
42.

Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.

Khatri VP, Baiocchi RA, Bernstein ZP, Caligiuri MA.

Cancer J Sci Am. 1997 Dec;3 Suppl 1:S129-36. Review.

PMID:
9457408
43.

Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome.

Baiocchi RA, Khatri VP, Lindemann MJ, Ross ME, Papoff G, Caprio AJ, Caprio TV, Fenstermaker R, Ruberti G, Bernstein ZP, Caligiuri MA.

Blood. 1997 Sep 1;90(5):1737-46.

PMID:
9292506
44.

Mechanism(S) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis.

Ambrus JL, Ambrus JL Jr, Chadha S, Novick D, Rubinstein M, Gopalakrishnan B, Bernstein Z, Priore RL, Chadha KC.

Res Commun Mol Pathol Pharmacol. 1997 Jun;96(3):255-65.

PMID:
9261885
45.

Intra-abdominal abscess and tumor-enteric fistula formation: an unusual complication of chemotherapy for advanced testicular choriocarcinoma.

Stein ME, Bernstein Z, Drumea K, Eyal A, Groisman GM, Lachter J, Haim N.

Ann Oncol. 1996 Jul;7(5):536-7. No abstract available.

46.

Bedside measurement of factor VIII:C activity in individuals with hemophilia A.

Kessler CM, Bernstein Z, Ghesani S, Shamsipour Z, Frances C, Zucker ML, LaDuca FM.

Am J Hematol. 1996 Mar;51(3):181-5.

47.

Advanced nasopharyngeal carcinoma and radiation-induced meningioma in dizygotic twins--a rare case report.

Stein ME, Drumea K, Bernstein Z, Daoud C, Zarour M, Kuten A.

Acta Oncol. 1996;35(6):761-2. No abstract available.

PMID:
8938229
48.

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.

Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E, et al.

Clin Cancer Res. 1995 Nov;1(11):1285-94.

49.

Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity.

Bernstein ZP, Porter MM, Gould M, Lipman B, Bluman EM, Stewart CC, Hewitt RG, Fyfe G, Poiesz B, Caligiuri MA.

Blood. 1995 Nov 1;86(9):3287-94.

PMID:
7579429
50.

Radiation-induced primary brain lymphoma: a case report.

Stein ME, Haim N, Ben-Shachar M, Goldsher D, Bernstein Z, Ben-Arieh Y, Kuten A.

Tumori. 1995 May-Jun;81(3):204-7.

PMID:
7571030

Supplemental Content

Loading ...
Support Center